Clinical Cancer Research Journal Issues Research Articles in Feb. 1, 2022 Edition
February 01, 2022
February 01, 2022
PHILADELPHIA, Pennsylvania, Feb. 1 -- Clinical Cancer Research, a journal from the American Association for Cancer Research that presents clinical and translational cancer research studies that bridge the laboratory and the clinic, published research articles, including the following topics, in its Feb. 1, 2022 edition:
Targeted Therapy:
* A Phase II Study of the Efficacy and Safety of Oral Selinexor in Recurrent Glioblastoma
Immunotherapy:
* . . .
Targeted Therapy:
* A Phase II Study of the Efficacy and Safety of Oral Selinexor in Recurrent Glioblastoma
Immunotherapy:
* . . .